Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- InCarda Therapeutics, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT05039359
- Locations
- 🇵🇱
Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu, Toruń, Poland
🇺🇸Bridgeport Hospital, Bridgeport, Connecticut, United States
🇺🇸University of Cincinnati College of Medicine, Cincinnati, Ohio, United States
INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- InCarda Therapeutics, Inc.
- Target Recruit Count
- 176
- Registration Number
- NCT03539302
- Locations
- 🇧🇪
Imelda, Bonheiden, Belgium
🇳🇱OLVG, Amsterdam, Netherlands
🇳🇱Deventer Ziekenhuis, Deventer, Netherlands
© Copyright 2025. All Rights Reserved by MedPath